These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36551314)

  • 1. Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme.
    Abramov-Harpaz K; Miller Y
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into the primary nucleation of polymorphic amyloid β dimers in DOPC lipid bilayer membrane.
    Press-Sandler O; Miller Y
    Protein Sci; 2022 May; 31(5):e4283. PubMed ID: 35129859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Primary Nucleation of Polymorphic Aβ Dimers Yields to Distinguished Fibrillation Pathways.
    Press-Sandler O; Miller Y
    ACS Chem Neurosci; 2019 Oct; 10(10):4407-4413. PubMed ID: 31532176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
    Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
    J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
    Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
    J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates.
    de Tullio MB; Castelletto V; Hamley IW; Martino Adami PV; Morelli L; Castaño EM
    PLoS One; 2013; 8(4):e59113. PubMed ID: 23593132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.
    Lauer AA; Mett J; Janitschke D; Thiel A; Stahlmann CP; Bachmann CM; Ritzmann F; Schrul B; Müller UC; Stein R; Riemenschneider M; Grimm HS; Hartmann T; Grimm MOW
    Aging Cell; 2020 Nov; 19(11):e13264. PubMed ID: 33128835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective.
    de Tullio MB; Morelli L; Castaño EM
    Prion; 2008; 2(2):51-6. PubMed ID: 19098445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
    Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity.
    Ramaraju B; Nelson SL; Zheng W; Ghirlando R; Deshmukh L
    Biochemistry; 2021 Aug; 60(33):2519-2523. PubMed ID: 34342986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's disease.
    Del Campo M; Stargardt A; Veerhuis R; Reits E; Teunissen CE
    Neurosci Lett; 2015 Mar; 589():47-51. PubMed ID: 25597881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
    Llovera RE; de Tullio M; Alonso LG; Leissring MA; Kaufman SB; Roher AE; de Prat Gay G; Morelli L; Castaño EM
    J Biol Chem; 2008 Jun; 283(25):17039-48. PubMed ID: 18411275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
    Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
    J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.
    Hubin E; Cioffi F; Rozenski J; van Nuland NA; Broersen K
    Biochim Biophys Acta; 2016 Jun; 1860(6):1281-90. PubMed ID: 26968463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
    Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
    PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
    Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
    Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Longest Amyloid-β Precursor Protein Intracellular Domain Produced with Aβ42 Forms β-Sheet-Containing Monomers That Self-Assemble and Are Proteolyzed by Insulin-Degrading Enzyme.
    Krasinski CA; Zheng Q; Ivancic VA; Spratt DE; Lazo ND
    ACS Chem Neurosci; 2018 Dec; 9(12):2892-2897. PubMed ID: 30067897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.